Comparison of increase respectively decrease of similar articles after publication of MSM < 50 respectively MSM ≥ 100 papers from <i>Nature</i> or <i>Science</i>. by Melanie Leidecker-Sandmann (6432155)

Results of the fitting process of the basic epidemiological model (i.e., without vaccinations). by Matthias Horn (78815)

NS affects the PI3K/AKT/mTOR pathway in RAW264.7 cells. by Yihua Wang (491766)

Determination of antagonism type for PP PLA₂. by Catherine A. Vulfius (676708)

Interaction of non-venom proteins with <i>T</i>.<i>californica</i> nAChR. by Catherine A. Vulfius (676708)

Plot of on <i>ϕ</i> & <i>δ</i>₂ with <i>M</i> = 0.2, <i>d</i>₁ = 0.2, <i>F</i> = 0.3, <i>d</i>₂ = 0.6, <i>L</i>₂ = <i>L</i>₁... by Mallinath Dhange (12988433)

SPR recordings of Cro interaction with AChBP from <i>L</i>. <i>stanalis</i>. by Catherine A. Vulfius (676708)

Inhibition of acetylcholine or cytisine-elicited current in <i>L</i>.<i>stagnalis</i> neurons by PP PLA₂ and β-Bgt. by Catherine A. Vulfius (676708)

Interaction of Cro with nAChR of <i>T</i>. <i>californica</i> electric organ, human neuronal α7 nAChR and AChBP. by Catherine A. Vulfius (676708)

Inhibition experiments with PP PLA₂. by Catherine A. Vulfius (676708)

Assessing the Potential of <i>N</i>‑Butyl‑l‑deoxynojirimycin (l‑NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent by Anna Esposito (2400814)

Initial treatment regimen. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Patients baseline characteristics. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Overall survival. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Progression-free survival by treatment. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Maintenance regimen and adverse event management. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

BCC-specific survival. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

HbA1c by age in new and previous diabetes diagnoses. by Sharon E. Cox (7243847)

Process of model building. by Gazi Md. Salahuddin Mamun (13905678)

“…Using these six predictors, we created a parsimonious model with a discriminatory performance of 0.691, as measured by area under the receiving operating curve (AUC). …”

De-identified external validation dataset. by Gazi Md. Salahuddin Mamun (13905678)

“…Using these six predictors, we created a parsimonious model with a discriminatory performance of 0.691, as measured by area under the receiving operating curve (AUC). …”